NFKB1 and colorectal cancer: Another study on the FOLFOX chemotherapy regimen (5-FU, leucovorin calcium and oxaliplatin) in a colorectal cancer model demonstrated that some microbiome compositions can induce the activation of nuclear transcription factor-κB (NF-κB) and increase the production of interleukin-6 (IL-6) and tumour necrosis factor (TNF), which promotes inflammation and causes mucosal damage [50].